Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: DICLOFENAC SODIUM 1.5% — Supplemental Application (SOLA Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for diclofenac sodium topical 1.5% from SOLA Pharmaceuticals, indicating an approved change related to this topical prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DICLOFENAC SODIUM 1.5% (diclofenac sodium topical)

Snippet

SUPPL AP for DICLOFENAC SODIUM 1.5% (DICLOFENAC SODIUM TOPICAL)